{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,28]],"date-time":"2026-07-28T00:26:39Z","timestamp":1785198399435,"version":"3.55.0"},"reference-count":25,"publisher":"Oxford University Press (OUP)","issue":"9","license":[{"start":{"date-parts":[[2022,8,27]],"date-time":"2022-08-27T00:00:00Z","timestamp":1661558400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/academic.oup.com\/pages\/standard-publication-reuse-rights"}],"funder":[{"name":"Department for Antidrug Policies"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2023,1,24]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:p>From 2014 onwards, illicit fentanyl and analogues have caused numerous intoxications and fatalities worldwide, impacting the demographics of opioid-related overdoses. The identification of cases involving fentanyl analogues is crucial in clinical and forensic settings to treat patients, elucidate intoxications, address drug use disorders and tackle drug trends. However, in analytical toxicology, the concentration of fentanyl analogues in biological matrices is low, making their detection challenging. Therefore, the identification of specific metabolite biomarkers is often required to document consumption. \u03b2\u2032-Phenylfentanyl (N-phenyl-N-[1-(2-phenylethyl)-4-piperidinyl]-benzenepropanamide) is a fentanyl analogue that was first detected in Sweden in 2017 and has recently reemerged onto the American illicit drug market. There is little data available on \u03b2\u2032-phenylfentanyl effects and toxicokinetics and its metabolism is yet to be studied. We aimed to investigate \u03b2\u2032-phenylfentanyl human metabolism to identify potential biomarkers of use. To assist in \u03b2\u2032-phenylfentanyl metabolite identification, a list of putative reactions was generated using in silico predictions with GLORYx freeware. \u03b2\u2032-phenylfentanyl was incubated with cryopreserved 10-donor-pooled human hepatocytes, analyses were performed by liquid chromatography\u2013high-resolution tandem mass spectrometry (LC\u2013HRMS-MS) and data were processed using a partially automated targeted\/untargeted approach with Compound Discoverer. We identified 26 metabolites produced by N-dealkylation, oxidation, hydroxylation, O-glucuronidation, O-methylation and combinations thereof. We suggest \u03b2\u2032-phenylnorfentanyl (N-phenyl-N-4-piperidinyl-benzenepropanamide) and further metabolites 1-oxo-N-phenyl-N-4-piperidinyl-benzenepropanamide and 1-hydroxy-N-phenyl-N-4-piperidinyl-benzenepropanamide as major biomarkers of \u03b2\u2032-phenylfentanyl use. In silico predictions were mostly wrong, and \u03b2\u2032-phenylfentanyl metabolic fate substantially differed from that of a closely related analogue incubated in the same conditions, highlighting the value of the experimental assessment of new psychoactive substance human metabolism. In vivo data are necessary to confirm the present results. However, the present results may be necessary to help analytical toxicologists identify \u03b2\u2032-phenylfentanyl-positive cases to provide authentic samples.<\/jats:p>","DOI":"10.1093\/jat\/bkac065","type":"journal-article","created":{"date-parts":[[2022,8,26]],"date-time":"2022-08-26T20:46:01Z","timestamp":1661546761000},"page":"e207-e217","source":"Crossref","is-referenced-by-count":15,"title":["\u03b2\u2032-Phenylfentanyl Metabolism in Primary Human Hepatocyte Incubations: Identification of Potential Biomarkers of Exposure in Clinical and Forensic Toxicology"],"prefix":"10.1093","volume":"46","author":[{"given":"Pietro","family":"Brunetti","sequence":"first","affiliation":[{"name":"Unit of Forensic Toxicology, Section of Legal Medicine, Department of Biomedical Sciences and Public Health, Marche Polytechnic University , Via Tronto 10\/a, Ancona AN 60126, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alfredo F","family":"Lo Faro","sequence":"additional","affiliation":[{"name":"Unit of Forensic Toxicology, Section of Legal Medicine, Department of Biomedical Sciences and Public Health, Marche Polytechnic University , Via Tronto 10\/a, Ancona AN 60126, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Annagiulia","family":"Di Trana","sequence":"additional","affiliation":[{"name":"Unit of Forensic Toxicology, Section of Legal Medicine, Department of Biomedical Sciences and Public Health, Marche Polytechnic University , Via Tronto 10\/a, Ancona AN 60126, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Angelo","family":"Montana","sequence":"additional","affiliation":[{"name":"Health Service Department, Italian State Police , Piazza Sant\u2019Ambrogio 5, Milan MI 20123, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Giuseppe","family":"Basile","sequence":"additional","affiliation":[{"name":"IRCCS Galeazzi Orthopedic Institute, Via Riccardo Galeazzi 4 , Milan MI 20161, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3332-9518","authenticated-orcid":false,"given":"Jeremy","family":"Carlier","sequence":"additional","affiliation":[{"name":"Unit of Forensic Toxicology, Section of Legal Medicine, Department of Biomedical Sciences and Public Health, Marche Polytechnic University , Via Tronto 10\/a, Ancona AN 60126, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Francesco P","family":"Busard\u00f2","sequence":"additional","affiliation":[{"name":"Unit of Forensic Toxicology, Section of Legal Medicine, Department of Biomedical Sciences and Public Health, Marche Polytechnic University , Via Tronto 10\/a, Ancona AN 60126, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2022,8,27]]},"reference":[{"key":"2023012411402657400_R1","article-title":"Current NPS Threats \u2013 Volume IV, November 2021","author":"United Nations Office on Drugs and Crime (UNODC)","year":"2021"},{"key":"2023012411402657400_R2","doi-asserted-by":"publisher","DOI":"10.3389\/fphar.2018.01210","article-title":"Postmortem toxicology of new synthetic opioids","volume":"9","author":"Concheiro","year":"2018","journal-title":"Frontiers in Pharmacology"},{"key":"2023012411402657400_R3","doi-asserted-by":"publisher","first-page":"537","DOI":"10.1093\/jat\/bkaa115","article-title":"A 2017\u20132019 update on acute intoxications and fatalities from illicit fentanyl and analogs","volume":"45","author":"Brunetti","year":"2021","journal-title":"Journal of Analytical Toxicology"},{"key":"2023012411402657400_R4","doi-asserted-by":"publisher","first-page":"494","DOI":"10.1097\/FTD.0000000000000970","article-title":"Acute intoxications and fatalities associated with benzimidazole opioid (nitazene analog) use: a systematic review","volume":"44","author":"Montanari","year":"2022","journal-title":"Therapeutic Drug Monitoring"},{"key":"2023012411402657400_R5","doi-asserted-by":"publisher","first-page":"256","DOI":"10.1097\/ADM.0000000000000324","article-title":"Misuse of novel synthetic opioids: a deadly new trend","volume":"11","author":"Prekupec","year":"2017","journal-title":"Journal of Addiction Medicine"},{"key":"2023012411402657400_R6","article-title":"The Growing Complexity of the Opioid Crisis","volume-title":"Global SMART update","author":"United Nations Office on Drugs and Crime (UNODC)","year":"2020"},{"key":"2023012411402657400_R7","doi-asserted-by":"publisher","first-page":"49","DOI":"10.1016\/j.neubiorev.2018.12.005","article-title":"Fentanyl: receptor pharmacology, abuse potential, and implications for treatment","volume":"106","author":"Comer","year":"2019","journal-title":"Neuroscience and Biobehavioral Reviews"},{"key":"2023012411402657400_R8","article-title":"EMCDDA-Europol 2017 Annual Report on the Implementation of Council Decision 2005\/387\/JHA","author":"European Monitoring Centre for Drugs and Drug Addiction (EMCDDA)","year":"2018"},{"key":"2023012411402657400_R9","article-title":"UNODC New Psychoactive Substances Portal and International Collaborative Exercise Portal","author":"United Nations Office on Drugs and Crime (UNODC)"},{"key":"2023012411402657400_R10","doi-asserted-by":"publisher","first-page":"65","DOI":"10.4155\/bio.15.237","article-title":"In vitro, in vivo and in silico metabolic profiling of \u03b1-pyrrolidinopentiothiophenone, a novel thiophene stimulant","volume":"8","author":"Swortwood","year":"2016","journal-title":"Bioanalysis"},{"key":"2023012411402657400_R11","doi-asserted-by":"publisher","first-page":"20","DOI":"10.1007\/s11419-016-0326-9","article-title":"In vitro and in vivo human metabolism of a new synthetic cannabinoid NM-2201 (CBL-2201)","volume":"35","author":"Diao","year":"2017","journal-title":"Forensic Toxicology"},{"key":"2023012411402657400_R12","doi-asserted-by":"publisher","first-page":"1102","DOI":"10.1208\/s12248-017-0070-z","article-title":"In vitro and in vivo metabolite identification studies for the new synthetic opioids acetylfentanyl, acrylfentanyl, furanylfentanyl, and 4-fluoro-Isobutyrylfentanyl","volume":"19","author":"Watanabe","year":"2017","journal-title":"The AAPS Journal"},{"key":"2023012411402657400_R13","doi-asserted-by":"publisher","first-page":"1989","DOI":"10.1007\/s00204-022-03289-z","article-title":"In silico, in vitro, and in vivo human metabolism of acetazolamide, a carbonic anhydrase inhibitor and common \u2018diuretic and masking agent\u2019 in doping","volume":"96","author":"Busard\u00f2","year":"2022","journal-title":"Archives of Toxicology"},{"key":"2023012411402657400_R14","doi-asserted-by":"publisher","DOI":"10.1016\/j.talanta.2021.122740","article-title":"In silico prediction, LC\u2013HRMS\/MS analysis, and targeted\/untargeted data-mining workflow for the profiling of phenylfentanyl in vitro metabolites","volume":"235","author":"Di Trana","year":"2021","journal-title":"Talanta"},{"key":"2023012411402657400_R15","doi-asserted-by":"publisher","first-page":"286","DOI":"10.1021\/acs.chemrestox.0c00224","article-title":"GLORYx: prediction of the metabolites resulting from phase 1 and phase 2 biotransformations of xenobiotics","volume":"34","author":"De Bruyn Kops","year":"2021","journal-title":"Chemical Research in Toxicology"},{"key":"2023012411402657400_R16","doi-asserted-by":"crossref","first-page":"1291","DOI":"10.1093\/bioinformatics\/btz695","article-title":"NERDD: a web portal providing access to in silico tools for drug discovery","volume":"36","author":"Stork","year":"2020","journal-title":"Bioinformatics"},{"key":"2023012411402657400_R17","doi-asserted-by":"publisher","first-page":"106","DOI":"10.1248\/bpb.b17-00709","article-title":"Metabolism of fentanyl and acetylfentanyl in human-induced pluripotent stem cell-derived hepatocytes","volume":"41","author":"Kanamori","year":"2018","journal-title":"Biological & Pharmaceutical Bulletin"},{"key":"2023012411402657400_R18","doi-asserted-by":"publisher","first-page":"2009","DOI":"10.1007\/s00204-020-02726-1","article-title":"Toxicokinetics and toxicodynamics of the fentanyl homologs cyclopropanoyl-1-benzyl-4\u00b4-fluoro-4-anilinopiperidine and furanoyl-1-benzyl-4-anilinopiperidine","volume":"94","author":"Gampfer","year":"2020","journal-title":"Archives of Toxicology"},{"key":"2023012411402657400_R19","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1007\/s00204-018-2330-9","article-title":"Correlations between metabolism and structural elements of the alicyclic fentanyl analogs cyclopropyl fentanyl, cyclobutyl fentanyl, cyclopentyl fentanyl, cyclohexyl fentanyl and 2,2,3,3-tetramethylcyclopropyl fentanyl studied by human hepatocytes and LC\u2013QTOF-MS","volume":"93","author":"\u00c5strand","year":"2019","journal-title":"Archives of Toxicology"},{"key":"2023012411402657400_R20","first-page":"1","article-title":"Pyrrolidinyl synthetic cathinones \u03b1-PHP and 4F-\u03b1-PVP metabolite profiling using human hepatocyte incubations","volume":"22","author":"Carlier","year":"2021","journal-title":"International Journal of Molecular Sciences"},{"key":"2023012411402657400_R21","doi-asserted-by":"publisher","DOI":"10.1016\/j.jchromb.2022.123162","article-title":"3F-\u03b1-pyrrolydinovalerophenone (3F-\u03b1-PVP) in vitro human metabolism: multiple in silico predictions to assist in LC\u2013HRMS\/MS analysis and targeted\/untargeted data mining","volume":"1193","author":"Carlier","year":"2022","journal-title":"Journal of Chromatography. B, Analytical Technologies in the Biomedical and Life Sciences"},{"key":"2023012411402657400_R22","doi-asserted-by":"publisher","first-page":"357","DOI":"10.2174\/1389200003338929","article-title":"The biotransformation of nitrogen containing xenobiotics to lactams","volume":"1","author":"Vickers","year":"2000","journal-title":"Current Drug Metabolism"},{"key":"2023012411402657400_R23","first-page":"1165","article-title":"An overview of benzene metabolism","volume":"104","author":"Snyder","year":"1996","journal-title":"Environmental Health Perspectives"},{"key":"2023012411402657400_R24","doi-asserted-by":"publisher","first-page":"6184","DOI":"10.1016\/S0021-9258(19)84546-5","article-title":"Regio- and stereospecificity of homogeneous 3 alpha-hydroxysteroid-dihydrodiol dehydrogenase for trans-dihydrodiol metabolites of polycyclic aromatic hydrocarbons","volume":"261","author":"Smithgall","year":"1986","journal-title":"The Journal of Biological Chemistry"},{"key":"2023012411402657400_R25","doi-asserted-by":"publisher","first-page":"13","DOI":"10.1021\/acs.chemrestox.6b00256","article-title":"Formation and biological targets of quinones: cytotoxic versus cytoprotective effects","volume":"30","author":"Bolton","year":"2017","journal-title":"Chemical Research in Toxicology"}],"container-title":["Journal of Analytical Toxicology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/academic.oup.com\/jat\/advance-article-pdf\/doi\/10.1093\/jat\/bkac065\/45799321\/bkac065.pdf","content-type":"application\/pdf","content-version":"am","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/jat\/article-pdf\/46\/9\/e207\/48844591\/bkac065.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/jat\/article-pdf\/46\/9\/e207\/48844591\/bkac065.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,2,16]],"date-time":"2023-02-16T03:23:29Z","timestamp":1676517809000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/jat\/article\/46\/9\/e207\/6677997"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,8,27]]},"references-count":25,"journal-issue":{"issue":"9","published-online":{"date-parts":[[2022,8,27]]},"published-print":{"date-parts":[[2023,1,24]]}},"URL":"https:\/\/doi.org\/10.1093\/jat\/bkac065","relation":{},"ISSN":["0146-4760","1945-2403"],"issn-type":[{"value":"0146-4760","type":"print"},{"value":"1945-2403","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2022,11,1]]},"published":{"date-parts":[[2022,8,27]]}}}